USD 0.0
(-66.17%)
Year | EBITDA | EBITDA Growth |
---|---|---|
2023 | -9.39 Million USD | -96.85% |
2022 | -5.4 Million USD | -17.07% |
2021 | -5.52 Million USD | 8.6% |
2020 | -7.45 Million USD | 21.48% |
2019 | -6.41 Million USD | 0.34% |
2018 | -5.43 Million USD | -17.93% |
2017 | -4.65 Million USD | -29.91% |
2016 | -3.71 Million USD | -5.05% |
2015 | -3.24 Million USD | -8.17% |
2014 | -3.24 Million USD | -15.63% |
2013 | -3.66 Million USD | 19.16% |
2012 | -3.35 Million USD | -11.18% |
2011 | -2.71 Million USD | 8.62% |
2010 | -2.95 Million USD | -15.16% |
2009 | -2.98 Million USD | 37.22% |
2008 | -4.7 Million USD | 31.87% |
2007 | -5.14 Million USD | -57.94% |
2006 | -3.91 Million USD | 21.81% |
2005 | -2.41 Million USD | -215.89% |
2004 | -2.24 Million USD | -870.43% |
2003 | -1.19 Million USD | 215.35% |
2002 | -201.8 Thousand USD | -121.82% |
2001 | 924.66 Thousand USD | 379.83% |
2000 | -1.79 Million USD | -147.21% |
1999 | -111.76 Thousand USD | -85.42% |
1998 | 344.1 Thousand USD | 140.0% |
1997 | 2.3 Million USD | 33.33% |
1996 | 1.5 Million USD | 0.0% |
Year | EBITDA | EBITDA Growth |
---|---|---|
2024 Q1 | -1.4 Million USD | 24.53% |
2023 Q2 | -1.05 Million USD | 70.71% |
2023 Q4 | -3.46 Million USD | -103.02% |
2023 Q3 | -1.7 Million USD | -61.62% |
2023 FY | - USD | -96.85% |
2023 Q1 | -3.6 Million USD | -142.42% |
2022 FY | - USD | -17.07% |
2022 Q2 | -869.85 Thousand USD | 17.53% |
2022 Q3 | -1.35 Million USD | -56.31% |
2022 Q4 | -1.48 Million USD | -9.33% |
2022 Q1 | -1.05 Million USD | 19.72% |
2021 FY | - USD | 8.6% |
2021 Q3 | -1.15 Million USD | -107.22% |
2021 Q1 | -1.04 Million USD | -3.13% |
2021 Q2 | -557.22 Thousand USD | 46.89% |
2021 Q4 | -1.31 Million USD | -13.78% |
2020 FY | - USD | 21.48% |
2020 Q1 | -1.35 Million USD | 28.38% |
2020 Q2 | -1.3 Million USD | 3.61% |
2020 Q3 | -789.58 Thousand USD | 39.33% |
2020 Q4 | -1.01 Million USD | -28.85% |
2019 Q2 | -1.56 Million USD | -5.7% |
2019 Q3 | -1.04 Million USD | 33.26% |
2019 Q4 | -1.88 Million USD | -80.78% |
2019 FY | - USD | 0.34% |
2019 Q1 | -1.47 Million USD | 30.51% |
2018 FY | - USD | -17.93% |
2018 Q4 | -2.12 Million USD | -133.76% |
2018 Q3 | -909.87 Thousand USD | 42.09% |
2018 Q2 | -1.57 Million USD | -44.87% |
2018 Q1 | -1.08 Million USD | 17.93% |
2017 Q2 | -1.38 Million USD | -39.22% |
2017 Q1 | -997.61 Thousand USD | 37.24% |
2017 FY | - USD | -29.91% |
2017 Q4 | -1.32 Million USD | -17.68% |
2017 Q3 | -1.12 Million USD | 19.15% |
2016 Q3 | -1.07 Million USD | -1.61% |
2016 FY | - USD | -5.05% |
2016 Q4 | -1.58 Million USD | -48.33% |
2016 Q1 | -1.03 Million USD | -11.95% |
2016 Q2 | -1.05 Million USD | -1.43% |
2015 Q1 | -867.9 Thousand USD | 4.13% |
2015 Q2 | -1.05 Million USD | -21.97% |
2015 FY | - USD | -8.17% |
2015 Q3 | -684.63 Thousand USD | 35.33% |
2015 Q4 | -928.73 Thousand USD | -35.65% |
2014 Q2 | -826.66 Thousand USD | -2651.25% |
2014 Q4 | -905.24 Thousand USD | -16.36% |
2014 FY | - USD | -15.63% |
2014 Q1 | -30.04 Thousand USD | 90.82% |
2014 Q3 | -778 Thousand USD | 5.89% |
2013 Q4 | -327.45 Thousand USD | 71.54% |
2013 Q3 | -1.15 Million USD | -65.72% |
2013 FY | - USD | 19.16% |
2013 Q2 | -694.22 Thousand USD | -5.5% |
2013 Q1 | -658.05 Thousand USD | 45.76% |
2012 Q4 | -1.21 Million USD | -115.74% |
2012 Q2 | -832.25 Thousand USD | 6.83% |
2012 Q3 | -562.32 Thousand USD | 32.43% |
2012 Q1 | -893.24 Thousand USD | -6.77% |
2012 FY | - USD | -11.18% |
2011 Q3 | -713.31 Thousand USD | 19.84% |
2011 FY | - USD | 8.62% |
2011 Q4 | -836.63 Thousand USD | -17.29% |
2011 Q2 | -889.86 Thousand USD | -12.21% |
2011 Q1 | -793.03 Thousand USD | 0.73% |
2010 Q1 | -861.45 Thousand USD | -18.59% |
2010 FY | - USD | -15.16% |
2010 Q4 | -798.9 Thousand USD | -0.72% |
2010 Q3 | -793.22 Thousand USD | -6.08% |
2010 Q2 | -747.74 Thousand USD | 13.2% |
2009 Q4 | -726.38 Thousand USD | -4.48% |
2009 FY | - USD | 37.22% |
2009 Q1 | -802.88 Thousand USD | 6.03% |
2009 Q2 | -770.08 Thousand USD | 4.09% |
2009 Q3 | -695.27 Thousand USD | 9.71% |
2008 Q3 | -1.05 Million USD | 31.28% |
2008 Q2 | -1.53 Million USD | -15.01% |
2008 FY | - USD | 31.87% |
2008 Q1 | -1.33 Million USD | -6.52% |
2008 Q4 | -854.42 Thousand USD | 18.74% |
2007 FY | - USD | -57.94% |
2007 Q4 | -1.24 Million USD | 6.0% |
2007 Q2 | -2.62 Million USD | -86.0% |
2007 Q1 | -1.41 Million USD | -36.69% |
2007 Q3 | -1.32 Million USD | 49.43% |
2006 Q4 | -1.03 Million USD | -30.92% |
2006 FY | - USD | 21.81% |
2006 Q2 | -1.1 Million USD | 25.98% |
2006 Q1 | -1.49 Million USD | 3.2% |
2006 Q3 | -789.43 Thousand USD | 28.8% |
2005 Q4 | -1.54 Million USD | 27.58% |
2005 Q2 | -711.78 Thousand USD | -291.1% |
2005 Q1 | -181.99 Thousand USD | 71.43% |
2005 FY | - USD | -215.89% |
2005 Q3 | -2.13 Million USD | -200.23% |
2004 FY | - USD | -870.43% |
2004 Q3 | -556.66 Thousand USD | -188.17% |
2004 Q2 | -193.17 Thousand USD | -317.57% |
2004 Q1 | 88.78 Thousand USD | 181.82% |
2004 Q4 | -636.9 Thousand USD | -14.41% |
2003 Q1 | 138.89 Thousand USD | -67.1% |
2003 FY | - USD | 215.35% |
2003 Q4 | -108.52 Thousand USD | -412.84% |
2003 Q3 | -487.95 Thousand USD | -79.32% |
2003 Q2 | -213.88 Thousand USD | 20.74% |
2002 Q2 | 87.01 Thousand USD | 116.92% |
2002 Q1 | -514.37 Thousand USD | -187.43% |
2002 FY | - USD | -121.82% |
2002 Q4 | 422.18 Thousand USD | 314.72% |
2002 Q3 | -196.62 Thousand USD | -325.98% |
2001 Q1 | 141.89 Thousand USD | -76.78% |
2001 Q4 | 588.29 Thousand USD | 473.91% |
2001 Q2 | 471.26 Thousand USD | 232.13% |
2001 Q3 | -157.33 Thousand USD | -133.39% |
2001 FY | - USD | 379.83% |
2000 FY | - USD | -147.21% |
2000 Q4 | 610.96 Thousand USD | 128.11% |
2000 Q3 | -2.17 Million USD | -1144.68% |
2000 Q2 | 93.55 Thousand USD | 147.25% |
2000 Q1 | -440.27 Thousand USD | -210.07% |
1999 Q1 | 45.16 Thousand USD | 166.67% |
1999 Q2 | 38.65 Thousand USD | -100.0% |
1999 Q3 | 100 Thousand USD | 0.0% |
1999 FY | - USD | -85.42% |
1999 Q4 | 400 Thousand USD | 300.0% |
1998 Q4 | -300 Thousand USD | -108.11% |
1998 Q3 | 3.7 Million USD | 640.0% |
1998 Q2 | 500 Thousand USD | 162.5% |
1998 Q1 | -800 Thousand USD | -172.73% |
1998 FY | - USD | 140.0% |
1997 Q2 | 100 Thousand USD | -87.5% |
1997 Q1 | 400 Thousand USD | 60.0% |
1997 FY | - USD | 33.33% |
1997 Q4 | 1.1 Million USD | 175.0% |
1997 Q3 | 500 Thousand USD | 300.0% |
1996 Q4 | 500 Thousand USD | 25.0% |
1996 FY | - USD | 0.0% |
1996 Q3 | 400 Thousand USD | 0.0% |
Name | EBITDA | EBITDA Difference |
---|---|---|
CVR Medical Corp. | - USD | Infinity% |
BioElectronics Corporation | -274.29 Thousand USD | -3323.714% |
IR-Med Inc. | -4.89 Million USD | -91.965% |
Polarean Imaging plc | -11.19 Million USD | 16.115% |
Medical Supply International USA, Inc. | 456.06 Thousand USD | 2159.138% |
Avitar, Inc. | -1.66 Million USD | -463.07% |
AVITA Medical, Inc. | -39.56 Million USD | 76.266% |
Manhattan Scientifics, Inc. | -1.16 Million USD | -706.779% |
Össur hf. | 137.38 Million USD | 106.836% |
Zecotek Photonics Inc. | -3.44 Million USD | -172.815% |
QHSLab, Inc. | -91.29 Thousand USD | -10186.554% |
Wellstar International, Inc. | -1.35 Million USD | -592.28% |
Össur hf. | 137.38 Million USD | 106.836% |
Bionovate Technologies Corp | - USD | Infinity% |
EKF Diagnostics Holdings plc | 9.77 Million USD | 196.08% |
Escalon Medical Corp. | -58.46 Thousand USD | -15963.536% |
Aurora Spine Corporation | -454.37 Thousand USD | -1966.76% |
BrainsWay Ltd. | -2.31 Million USD | -306.357% |
Lattice Biologics Ltd. | - USD | Infinity% |
NewCardio, Inc. | -9.37 Million USD | -0.123% |
Hamilton Thorne Ltd. | 5.52 Million USD | 270.075% |
Vivos Inc. | -2.79 Million USD | -236.212% |
MicroPort Scientific Corporation | -347.57 Million USD | 97.298% |
Kelyniam Global, Inc. | -197.69 Thousand USD | -4650.294% |
REMSleep Holdings, Inc. | -1.66 Million USD | -462.817% |
CYduct Diagnostics, Inc. | -378.9 Thousand USD | -2378.426% |
Nanomix Corporation | -8.13 Million USD | -15.371% |
Theraclion SA | -2.05 Million USD | -357.917% |
Lifeline Biotechnologies, Inc. | - USD | Infinity% |
Wellness Center USA, Inc. | -707.03 Thousand USD | -1228.219% |
Positron Corporation | -1.45 Million USD | -546.689% |
Rafina Innovations Inc. | - USD | Infinity% |
Electromedical Technologies, Inc. | -1.72 Million USD | -445.385% |
Lombard Medical, Inc. | -28.06 Million USD | 66.542% |
ALR Technologies Inc. | -6.4 Million USD | -46.726% |
Stratec SE | 39.91 Million USD | 123.528% |
Vycor Medical, Inc. | 100.94 Thousand USD | 9403.175% |
Heart Tronics, Inc. | -14.85 Million USD | 36.791% |
Nu-Med Plus, Inc. | -118.25 Thousand USD | -7840.963% |
Perimeter Medical Imaging AI, Inc. | -13.27 Million USD | 29.269% |
SANUWAVE Health, Inc. | -9.15 Million USD | -2.61% |
VMS Rehab Systems, Inc. | -68.55 USD | -13699249.38% |
Guided Therapeutics, Inc. | -3.12 Million USD | -200.413% |
Ingen Technologies, Inc. | -8639.00 USD | -108603.6% |
Odyssey Group International, Inc. | -2.13 Million USD | -339.223% |
United American Healthcare Corporation | -59 Thousand USD | -15816.786% |
ECGI Holdings, Inc. | -2.99 Million USD | -214.032% |
Capital Group Holdings, Inc. | -629.18 Thousand USD | -1392.555% |
ADM Tronics Unlimited, Inc. | -514.02 Thousand USD | -1726.935% |
Urologix, Inc. | -6.34 Million USD | -48.028% |
Rapid Therapeutic Science Laboratories, Inc. | -1.23 Million USD | -657.721% |
Nexeon MedSystems Inc. | -765.96 Thousand USD | -1126.019% |
SS Innovations International, Inc. | -20.37 Million USD | 53.912% |
Qualis Innovations, Inc. | -222.81 Thousand USD | -4114.607% |
Smith & Nephew plc | 1 Billion USD | 100.937% |
NIOX Group Plc | 11.07 Million USD | 184.793% |
Fuse Medical, Inc. | 1.83 Million USD | 611.678% |
Broncus Holding Corporation | -25.19 Million USD | 62.733% |
Brain Scientific Inc. | -7.93 Million USD | -18.367% |
Health Logic Interactive Inc. | -18.4 Thousand USD | -50937.522% |